Puration Announces $100,000 December Sale Putting First Revenue On Books In 2016
December 19 2016 - 10:05AM
InvestorsHub NewsWire
Puration Announces $100,000
December Sale Putting First Revenue On Books In 2016
Dallas, TX December 19, 2016 -- InvestorsHub NewsWire
-- Puration, Inc. (PURA)
today announced a $100,000 one-time sale to be realized entirely in
the current month of December.
Puration entered the cannabis extraction business last year in
2015 acquiring a proprietary cannabis extraction technology. The
Company has recently signed two collaboration agreements to infuse
its cannabis extract into beverages generating revenue from the new
cannabis extraction business starting in 2017. The first beverage
expected to hit shelves early next year is the EVERx CBD Infused Bottled Water
in production now as a part of a collaboration agreement with
Alkame Water (ALKM). Puration anticipates generating $1 million in
EVERx CBD Infused Bottled Water sales next year.
The sale announced today results from the Purations previous
water filter business. The Company has made a $100,000 one-time
sale of water bottles produced and inventoried prior to its entry
into the cannabis extraction business.
To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/
Disclaimer/Safe Harbor: This news release contains
forward-looking statements within the meaning of the Securities
Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and
uncertainties. Among others, these risks include the expectation
that Alkame will achieve significant sales, the failure to meet
schedule or performance requirements of the Company's contracts,
the Company's liquidity position, the Company's ability to obtain
new contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkame (CE) (USOTC:ALKM)
Historical Stock Chart
From Apr 2023 to Apr 2024